These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 6649586
1. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias]. Apostolov I, Naumova R, Balabanski L, Goranov I. Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586 [Abstract] [Full Text] [Related]
2. [High density lipoprotein cholesterol in secondary hyperlipoproteinemias]. Titov VN, Tvorogova MG, Kantardzhian IG, Alamdarova IA, Negovskaia AV. Lab Delo; 1983; (12):11-7. PubMed ID: 6201650 [Abstract] [Full Text] [Related]
3. [Changes in serum lipoproteins in patients with ischemic heart disease at an early age]. Malamov E, Kiriakov A, Tsenov I, Kavrukova Iu, Kusitasev G. Vutr Boles; 1982; 21(2):91-8. PubMed ID: 7101895 [Abstract] [Full Text] [Related]
4. [Clinical research on the hypolipidemic action of a probucol preparation]. Naumova R, Kerekovska M, Goranov I, Balabanski L. Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382 [Abstract] [Full Text] [Related]
5. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia]. Tvorogova MG, Rozhkova TA, Semenova OA, Lupanov VP, Nuraliev EIu, Kukharchuk VV, Titov VN. Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530 [Abstract] [Full Text] [Related]
6. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias]. Kiriakov A, Malamov E, Apostolova Iu, Tsenov I, Tinterova Z. Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587 [Abstract] [Full Text] [Related]
7. [Features of lipid metabolism in patients of different sexes and ages with dyscirculatory encephalopathy]. Shprakh VV, Burtsev EM, Ruzhnikova TV, Naumova TV. Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1308-13. PubMed ID: 4072526 [Abstract] [Full Text] [Related]
8. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Noseda G, Fragiacomo C, Weidmann P, Bachmann C. Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1875-7. PubMed ID: 7455660 [Abstract] [Full Text] [Related]
9. Lipid abnormalities in coronary heart disease: a population-based case-control study. Gupta R, Kaul V, Prakash H, Sarna M, Singhal S, Gupta VP. Indian Heart J; 2001 Dec 06; 53(3):332-6. PubMed ID: 11516034 [Abstract] [Full Text] [Related]
10. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings. Vessby B, Lithell H, Boberg J. Hum Nutr Clin Nutr; 1982 Dec 06; 36(3):203-11. PubMed ID: 6749766 [Abstract] [Full Text] [Related]
14. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V, Wechsler JG, Klör HU, Ditschuneit H. Arzneimittelforschung; 1983 Dec 06; 33(5):776-9. PubMed ID: 6683558 [Abstract] [Full Text] [Related]
17. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia. Brook JG, Aviram M, Luboshitzky R, Barzilai D. Isr J Med Sci; 1981 May 06; 17(5):318-22. PubMed ID: 7263188 [Abstract] [Full Text] [Related]
18. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R. Artery; 1982 May 06; 10(4):266-85. PubMed ID: 7181672 [Abstract] [Full Text] [Related]
19. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]. Schiffl H, Weidmann P, Fragiacomo C, Noseda G, Bachmann C. Schweiz Med Wochenschr; 1985 Jun 29; 115(26):907-11. PubMed ID: 3927481 [Abstract] [Full Text] [Related]